Folkert W. Asselbergs

56.9k total citations · 4 hit papers
470 papers, 10.9k citations indexed

About

Folkert W. Asselbergs is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Folkert W. Asselbergs has authored 470 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 282 papers in Cardiology and Cardiovascular Medicine, 87 papers in Molecular Biology and 80 papers in Surgery. Recurrent topics in Folkert W. Asselbergs's work include Heart Failure Treatment and Management (63 papers), Cardiomyopathy and Myosin Studies (56 papers) and Cardiovascular Function and Risk Factors (54 papers). Folkert W. Asselbergs is often cited by papers focused on Heart Failure Treatment and Management (63 papers), Cardiomyopathy and Myosin Studies (56 papers) and Cardiovascular Function and Risk Factors (54 papers). Folkert W. Asselbergs collaborates with scholars based in Netherlands, United Kingdom and United States. Folkert W. Asselbergs's co-authors include Jason H. Moore, Scott M. Williams, Wiek H. van Gilst, Hans L. Hillege, Peter Atadja, Lin Gao, Maria A. Cueto, Dirk J. van Veldhuisen, Adriaan A. Voors and Pim van der Harst and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

Folkert W. Asselbergs

450 papers receiving 10.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family

2002 552 citations Folkert W. Asselbergs et al. profile →
A Genotype-Guided Strategy for Oral P2Y ₁₂ Inhibitors in Primary PCI

2019 378 citations Daniel M.F. Claassens, Gerrit J.A. Vos et al. New England Journal of Medicine profile →
Genetic drug target validation using Mendelian randomisation

2020 267 citations Amand F. Schmidt, Chris Finan et al. profile →
Heart failure risk stratification using artificial intelligence applied to electrocardiogram images: a multinational study

2025 20 citations Lovedeep Singh Dhingra, Arya Aminorroaya et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Folkert W. Asselbergs Netherlands	47	5.1k	2.8k	1.7k	1.2k	1.0k	470	10.9k
Iftikhar J. Kullo United States	53	2.6k 0.5×	1.9k 0.7×	2.3k 1.4×	1.6k 1.2×	911 0.9×	289	9.3k
Martin Landray United Kingdom	37	2.1k 0.4×	1.4k 0.5×	1.5k 0.9×	2.1k 1.7×	1.2k 1.2×	124	11.4k
Tong Liu China	58	5.9k 1.1×	3.1k 1.1×	1.8k 1.1×	330 0.3×	1.3k 1.3×	722	14.0k
David L. DeMets United States	52	3.9k 0.8×	1.2k 0.4×	1.9k 1.2×	1.2k 0.9×	1.7k 1.7×	163	14.3k
Amit V. Khera United States	34	3.3k 0.6×	2.3k 0.8×	2.2k 1.3×	3.4k 2.7×	1.3k 1.3×	104	11.5k
Juan P. Casas United Kingdom	46	2.3k 0.4×	1.1k 0.4×	1.2k 0.7×	965 0.8×	977 1.0×	127	8.5k
Eric J.G. Sijbrands Netherlands	59	3.1k 0.6×	2.0k 0.7×	5.1k 3.0×	1.2k 1.0×	3.1k 3.1×	276	12.5k
Hiroyuki Daida Japan	52	5.5k 1.1×	2.2k 0.8×	4.8k 2.8×	431 0.3×	2.3k 2.2×	737	14.1k
Sungha Park South Korea	49	4.0k 0.8×	1.1k 0.4×	1.8k 1.1×	300 0.2×	1.1k 1.1×	451	9.3k
Sekar Kathiresan United States	53	3.2k 0.6×	3.2k 1.1×	3.2k 1.9×	4.7k 3.8×	2.3k 2.2×	106	13.8k

Countries citing papers authored by Folkert W. Asselbergs

Since Specialization

Citations

This map shows the geographic impact of Folkert W. Asselbergs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Folkert W. Asselbergs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Folkert W. Asselbergs more than expected).

Fields of papers citing papers by Folkert W. Asselbergs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Folkert W. Asselbergs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Folkert W. Asselbergs. The network helps show where Folkert W. Asselbergs may publish in the future.

Co-authorship network of co-authors of Folkert W. Asselbergs

This figure shows the co-authorship network connecting the top 25 collaborators of Folkert W. Asselbergs. A scholar is included among the top collaborators of Folkert W. Asselbergs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Folkert W. Asselbergs. Folkert W. Asselbergs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dhingra, Lovedeep Singh, Arya Aminorroaya, Veer Sangha, et al.. (2025). Heart failure risk stratification using artificial intelligence applied to electrocardiogram images: a multinational study. European Heart Journal. 46(11). 1044–1053. 20 indexed citations breakdown →

Vugt, Marion van, Chris Finan, Sandesh Chopade, et al.. (2024). Integrating metabolomics and proteomics to identify novel drug targets for heart failure and atrial fibrillation. Genome Medicine. 16(1). 120–120. 5 indexed citations

Jansen, M., Remco de Brouwer, Amand F. Schmidt, et al.. (2023). Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies. JACC Heart Failure. 12(1). 134–147. 9 indexed citations

Oosterhoff, Loes A., Hedwig S. Kruitwagen, J.C.M. Vernooij, et al.. (2023). Locational memory of macrovessel vascular cells is transcriptionally imprinted. Scientific Reports. 13(1). 13028–13028. 1 indexed citations

Brugts, Jasper J., Lars H. Lund, Gerard C.M. Linssen, et al.. (2023). Identifying distinct clinical clusters in heart failure with mildly reduced ejection fraction. International Journal of Cardiology. 386. 83–90. 9 indexed citations

Asselbergs, Folkert W., Spiros Denaxas, Daniel L. Oberski, & Jason H. Moore. (2023). Clinical Applications of Artificial Intelligence in Real-World Data. 2 indexed citations

Wilson, M.G.F., et al.. (2022). Integrated rapid-cycle comparative effectiveness trials using flexible point of care randomisation in electronic health record systems. Journal of Biomedical Informatics. 137. 104273–104273. 2 indexed citations

Papež, Václav, Erica A. Voss, Elena Garcia Lara, et al.. (2022). Transforming and evaluating the UK Biobank to the OMOP Common Data Model for COVID-19 research and beyond. Journal of the American Medical Informatics Association. 30(1). 103–111. 27 indexed citations

Gill, Simrat, Karina V Bunting, Claudio Sartini, et al.. (2022). Smartphone detection of atrial fibrillation using photoplethysmography: a systematic review and meta-analysis. Heart. 108(20). 1600–1607. 34 indexed citations

10.

Vonk, Jet M. J., Yaakov Stern, Folkert W. Asselbergs, et al.. (2022). The role of cognitive and brain reserve in memory decline and atrophy rate in mid and late-life: The SMART-MR study. Cortex. 148. 204–214. 13 indexed citations

11.

Vugt, Marion van, Bram Ruijsink, Jessica van Setten, et al.. (2022). Prevalence and Disease Expression of Pathogenic and Likely Pathogenic Variants Associated With Inherited Cardiomyopathies in the General Population. Circulation Genomic and Precision Medicine. 15(6). e003704–e003704. 34 indexed citations

12.

Jansen, M., Imke Christiaans, Saskia N. van der Crabben, et al.. (2021). BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status. Netherlands Heart Journal. 29(6). 318–329. 6 indexed citations

13.

Al‐Rubaish, Abdullah M., Fahad Al‐Muhanna, Abdullah Alshehri, et al.. (2021). Prevalence of CYP2C19*2 carriers in Saudi ischemic stroke patients and the suitability of using genotyping to guide antiplatelet therapy in a university hospital setup. Drug Metabolism and Personalized Therapy. 37(1). 35–40. 6 indexed citations

14.

Peters, Tricia M., Michael V. Holmes, J. Brent Richards, et al.. (2020). Sex Differences in the Risk of Coronary Heart Disease Associated With Type 2 Diabetes: A Mendelian Randomization Analysis. Diabetes Care. 44(2). 556–562. 26 indexed citations

15.

Howe, Laurence J, Frank Dudbridge, Amand F. Schmidt, et al.. (2020). Polygenic risk scores for coronary artery disease and subsequent event risk amongst established cases. Human Molecular Genetics. 29(8). 1388–1395. 23 indexed citations

16.

Claassens, Daniel M.F., Gerrit J.A. Vos, Thomas O. Bergmeijer, et al.. (2019). A Genotype-Guided Strategy for Oral P2Y ₁₂ Inhibitors in Primary PCI. New England Journal of Medicine. 381(17). 1621–1631. 378 indexed citations breakdown →

17.

Linschoten, Marijke, Maarten J. Cramer, Eelke Gort, et al.. (2019). Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics. JACC CardioOncology. 1(2). 280–290. 21 indexed citations

18.

Haitjema, Saskia, Daniel Kofink, Jessica van Setten, et al.. (2017). Loss of Y Chromosome in Blood Is Associated With Major Cardiovascular Events During Follow-Up in Men After Carotid Endarterectomy. Circulation Cardiovascular Genetics. 10(4). e001544–e001544. 70 indexed citations

19.

Gho, Johannes M.I.H., Stefan Koudstaal, Sanne J. Jansen of Lorkeers, et al.. (2013). Cell Therapy, a Novel Remedy for Dilated Cardiomyopathy? A Systematic Review. Journal of Cardiac Failure. 19(7). 494–502. 21 indexed citations

20.

Lipšic, Erik, et al.. (2005). Anaemia predicts cardiovascular events in patients with stable coronary artery disease.. PubMed Central. 13(7-8). 254–258. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact